Oscillibacter is a genus of Gram-negative, strictly anaerobic, motile bacteria within the family Oscillospiraceae (phylum Firmicutes). The type species, Oscillibacter valericigenes, was first isolated from the alimentary tract of a Japanese freshwater fish and named for its characteristic oscillating motility and its production of valerate (pentanoic acid), a five-carbon short-chain fatty acid that distinguishes it from the more commonly discussed butyrate and propionate producers.
Oscillibacter is ecologically important as a sentinel of heavy metal exposure. Its depletion under cadmium and lead stress has been documented in multiple animal models, positioning it alongside lachnospiraceae family and roseburia as an early casualty of metal-driven dysbiosis.
Metal Dependencies
Oscillibacter depends on iron for its anaerobic metabolism:
- Iron-sulfur cluster proteins are essential for its electron transport chain and fermentation pathways.
- This iron dependency makes Oscillibacter vulnerable to toxic metal displacement. Lead exposure (100-500 ppm, 8 weeks) in Balb/C mice significantly decreased Oscillibacter alongside Lachnospiraceae and Ruminococcaceae, with concurrent increases in oxidative stress defense pathways (rosenfeld 2017 gut dysbiosis animals environmental chemicals, animal-model).
- Cadmium exposure in wild long-tailed dwarf hamsters significantly decreased Oscillibacter, identifying it as one of 14 potential pathogens/commensals affected by Cd perturbation (tao 2024 cadmium gut microbiota dwarf hamsters, animal-model).
Key Enzymes and Virulence Factors
Oscillibacter is not pathogenic. Its key metabolic enzymes reflect a saccharolytic fermentation strategy:
- Valerate synthesis enzymes: The genus's defining metabolic feature is production of valerate from carbohydrate fermentation. Valerate has immunomodulatory properties and may influence epithelial differentiation, though it is less studied than butyrate.
- Butyrate production: Some Oscillibacter species also produce butyrate, contributing to the overall SCFA pool.
- Bile acid metabolism: Oscillibacter has been implicated in secondary bile acid transformation, linking it to lipid metabolism and cholesterol homeostasis.
Ecological Role
In the healthy gut, Oscillibacter is a moderately abundant member of the Firmicutes community that contributes to the SCFA pool and bile acid metabolism. Its ecological significance becomes apparent under stress:
- Metal exposure indicator: The reproducible depletion of Oscillibacter under both cadmium and lead exposure makes it a candidate biomarker for environmental metal stress on the gut microbiome.
- Diet-responsive: On a low-carbohydrate, high-fat (non-ketogenic) diet, Oscillibacter was enriched alongside Escherichia/Shigella, and this LCD-associated community worsened colitis outcomes in mice — contrasting with the ketogenic diet, which enriched beneficial Akkermansia and Roseburia instead (kong 2021 ketogenic diet colitis ilc3 microbiome, animal-model).
- Metformin response: Oscillibacter increased in both healthy and T2D subjects after metformin treatment (elbere 2020 baseline gut microbiome metformin efficacy t2d, prospective-cohort).
- Cancer ecology: In CRC tumor tissue, Oscillibacter abundance correlated with steroid biosynthesis and terpenoid pathways (loke 2018 metabolomics 16s crc mucosa, cross-sectional). After FMT in CRC mice, Oscillibacter was negatively correlated with anti-cancer cytokines, suggesting its reduction may be beneficial in the tumor microenvironment (yu 2023 fmt inhibits crc progression, animal-model).
Conditions Associated
Depleted in:
- Cadmium exposure: Significantly decreased in wild hamsters exposed to CdCl2, identified among the most affected commensals (tao 2024 cadmium gut microbiota dwarf hamsters, animal-model).
- Lead exposure: Decreased alongside Lachnospiraceae and Ruminococcaceae in lead-exposed mice (rosenfeld 2017 gut dysbiosis animals environmental chemicals, animal-model).
Enriched in:
- Low-carb diet (non-ketogenic): Enriched on LCD but associated with worse colitis outcomes (kong 2021 ketogenic diet colitis ilc3 microbiome, animal-model).
- Metformin treatment: Increased in both healthy and T2D subjects after metformin (elbere 2020 baseline gut microbiome metformin efficacy t2d, prospective-cohort).
Complex associations:
- Colorectal cancer: Tumor tissue associations with steroid/terpenoid metabolism; negatively correlated with anti-cancer cytokines after FMT (loke 2018 metabolomics 16s crc mucosa, cross-sectional; yu 2023 fmt inhibits crc progression, animal-model).
Key Studies
| Study | Finding | Evidence Level |
|---|---|---|
| tao 2024 cadmium gut microbiota dwarf hamsters | Significantly depleted by cadmium in wild hamsters | Animal model |
| rosenfeld 2017 gut dysbiosis animals environmental chemicals | Depleted by lead alongside Lachnospiraceae | Animal model |
| yu 2023 fmt inhibits crc progression | Negatively correlated with anti-cancer cytokines post-FMT | Animal model |
| kong 2021 ketogenic diet colitis ilc3 microbiome | Enriched on LCD; worse colitis vs KD | Animal model |
| elbere 2020 baseline gut microbiome metformin efficacy t2d | Increased by metformin in healthy and T2D | Prospective cohort |
Cross-References
- cadmium — dose-dependent depletion
- lead — co-depleted with Lachnospiraceae
- lachnospiraceae family — co-depleted metal-sensitive family
- roseburia — co-depleted SCFA producer
- butyrate — related metabolic output
- short chain fatty acids — valerate production
- colorectal cancer — tumor tissue ecology
- metformin — drug-microbiome interaction